Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	37.36	-10.71	-17.09
Graham Fair Price	-2.20	16.82	17.20
PEG	4215.68	-0.77	0.02
Price/Book	-19.53	2.80	3.47
Price/Cash Flow	48.23	-19.20	-37.09
Prices/Earnings	32.73	-4.86	-7.23
Price/Sales	355.17	28092.42	6171.82
Price/FCF	48.23	-19.20	-37.09
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	62.13	-16.74	-44.21
Operating Margin	-556.25	-1630.56	-248.47
ROA	-19.63	-0.12	-0.10
ROE	-0.12	-0.14	-19.62
ROIC	-0.13	-0.15	-17.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	0.10	-45.49
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-8.62	-0.04	99.55
EPS QOQ	-4.07	-0.06	98.44
FCF QOQ	-6.79	-0.39	94.24
Revenue QOQ	-1.00	-0.84	15.51
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-32.50	0.00	inf
Days Sales Outstanding (DSO)	1469.34	0.00	inf
Inventory Turnover	-2.77	0.00	inf
Debt/Capitalization	0.02	0.02	17.54
Quick Ratio	10.99	12.63	14.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.46	9.35	-10.58
Cash	11.56	10.17	-11.95
Capex	-0.03	< 0.005	93.36
Free Cash Flow	-0.98	-1.36	-38.99
Revenue	< 0.005	< 0.005	-84.19
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	11.24	13.08	16.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.75	6.57	-15.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating